Victrex's (VCT) Buy Rating Reaffirmed at Canaccord Genuity Group

Key Points

• Canaccord Genuity reaffirmed a Buy rating on Victrex with a GBX 725 price target, implying roughly a 16.94% upside from the stock's current level.
• JPMorgan cut its price target to GBX 625 but maintained a Buy rating; analysts are split (2 Buy, 3 Hold) leaving a MarketBeat consensus of Hold with an average target of GBX 750.
• Shares opened at GBX 620; Victrex trades in a 52-week range of GBX 515–935, has a market cap of £540.17m and a P/E of 19.5, indicating mixed valuation metrics.

Victrex (LON:VCT - Get Free Report)'s stock had its "buy" rating reissued by investment analysts at Canaccord Genuity Group in a research report issued on Monday,London Stock Exchange reports. They currently have a GBX 725 price objective on the stock. Canaccord Genuity Group's price objective would indicate a potential upside of 16.94% from the stock's current price.

Separately, JPMorgan Chase & Co. cut their price target on shares of Victrex from GBX 725 to GBX 625 and set a "buy" rating on the stock in a report on Wednesday, March 18th. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of GBX 750.

Victrex Price Performance

Shares of LON VCT opened at GBX 620 on Monday. Victrex has a fifty-two week low of GBX 515 and a fifty-two week high of GBX 935. The company has a 50 day simple moving average of GBX 634.99 and a two-hundred day simple moving average of GBX 651.36. The company has a market capitalization of £540.17 million, a price-to-earnings ratio of 19.50, a P/E/G ratio of 1.92 and a beta of 0.75. The company has a debt-to-equity ratio of 11.30, a quick ratio of 1.99 and a current ratio of 3.01.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.